논문 목록
13건 · 최신순-
A comparison of Breast Implant Illness-related symptoms between breast cancer survivors and breast augmentation recipients.
[BACKGROUND] 'Breast Implant Illness' (BII) refers to non-specific constitutional, rheumatic, mental and cognitive symptoms experienced by women with silicone breast implants (SBIs). This potential late effect of SBIs challenges the safety …
-
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a type of T-cell lymphoma arising near textured breast implants. In a Dutch population, a higher prevalence of BRCA1/2 was found in BIA-ALCL. We analyzed the risk of BIA…
-
Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.
The optimal treatment of patients with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) that underwent incomplete resection, have advanced stage disease or relapse after resection remains unknown. We describe the treatmen…
-
[Silicone breast implants: the importance of nuanced reporting].
Silicone breast implants (SBIs) are frequently discussed in the media. Reporting on this topic is commonly characterised by sensationalism and a lack of nuance. SBIs have been linked to autoimmune disease and the controversial disease entit…
-
2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.
[BACKGROUND] Laboratory and clinical research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is rapidly evolving. Changes in standard of care and insights into best practice were recently presented at the 3rd World C…
- Bradford Hill and breast implant illness: no evidence for causal association with breast implants.
-
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a very rare type of T-cell lymphoma that is uniquely caused by a single environmental stimulus. Here, we present a comprehensive genetic analysis of a relatively large s…
-
Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition.
The first case of breast implant-associated anaplastic large cell lymphoma (breast implant ALCL) was described by John Keech and the late Brevator Creech in 1997. In the following 2 decades, much research has led to acceptance of breast imp…
-
The Dutch Breast Implant Registry: Registration of Breast Implant-Associated Anaplastic Large Cell Lymphoma-A Proof of Concept.
[BACKGROUND] The Dutch Breast Implant Registry (DBIR) was established in April of 2015 and currently contains information on 38,000 implants in 18,000 women. As a clinical registry, it evaluates the quality of breast implant surgery, includ…
-
A practical cytological approach to the diagnosis of breast-implant associated anaplastic large cell lymphoma.
The role of cytopathology in malignant lymphoma is largely restricted to primary screening in patients with lymphadenopathy of unknown causes and evaluation of relapse and transformation during follow-up of patients with known and fully cla…
- Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply.
-
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
[UNLABELLED] Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare but serious complication in patients with breast implants, Patients are at risk of BIA-ALCL whether they receive breast implants for cosmetic reasons…
-
Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.
[PURPOSE] Breast implant-associated anaplastic large-cell lymphoma (ALCL) is a recently described clinicopathologic entity that usually presents as an effusion-associated fibrous capsule surrounding an implant. Less frequently, it presents …